This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
A sticker reading, "COVID-19/Coronavirus vaccine/Injection only" and a medical syringe in front of a displayed Novavax logo in a photo illustration taken on Oct. 31, 2020. Dado Ruvic/Illustration/Reuters
The Centers for Disease Control and Prevention (CDC) on Monday signed off on the use of Novavax Inc.’s COVID-19 vaccine for adolescents aged 12 through 17.
The recommendation follows the Food and Drug Administration’s (FDA) authorization for the vaccine for the age group last week.
